Clinical trial
A Pilot Study to Investigate the Relative Effectiveness and Safety of Chemical Wound Debridement and Curettage in the Treatment of Venous and Mixed Aetiology Leg Ulcers.
NCT06652360 is registered in ClinicalTrials.gov with DEBx Medical B.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Investigate the Relative Effectiveness and Safety of Chemical Wound Debridement and Curettage in the Treatment of Venous and Mixed Aetiology Leg Ulcers.
- Lead sponsor
- DEBx Medical B.V.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 18, 2024
- Completion date
- February 23, 2026
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mixed ulcer, venous leg ulcers